94 related articles for article (PubMed ID: 7723585)
1. Anticonvulsant activity of caramiphen analogs.
DeHaven-Hudkins DL; Allen JT; Hudkins RL; Stubbins JF; Tortella FC
Life Sci; 1995; 56(19):1571-6. PubMed ID: 7723585
[TBL] [Abstract][Full Text] [Related]
2. Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats.
Tortella FC; Witkin JM; Musacchio JM
Eur J Pharmacol; 1988 Oct; 155(1-2):69-75. PubMed ID: 3243332
[TBL] [Abstract][Full Text] [Related]
3. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices.
Thurgur C; Church J
Br J Pharmacol; 1998 Jul; 124(5):917-29. PubMed ID: 9692777
[TBL] [Abstract][Full Text] [Related]
4. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin.
DeHaven-Hudkins DL; Ford-Rice FY; Allen JT; Hudkins RL
Life Sci; 1993; 53(1):41-8. PubMed ID: 8515681
[TBL] [Abstract][Full Text] [Related]
6. RLH-033, a novel, potent and selective ligand for the sigma 1 recognition site.
Hudkins RL; Mailman RB; DeHaven-Hudkins DL
Eur J Pharmacol; 1994 Dec; 271(1):235-6. PubMed ID: 7698207
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 3-substituted 17-methylmorphinan analogs as potential anticonvulsant agents.
Newman AH; Bevan K; Bowery N; Tortella FC
J Med Chem; 1992 Oct; 35(22):4135-42. PubMed ID: 1433216
[TBL] [Abstract][Full Text] [Related]
8. Novel 1-phenylcycloalkanecarboxylic acid derivatives are potent and selective sigma 1 ligands.
Calderon SN; Izenwasser S; Heller B; Gutkind JS; Mattson MV; Su TP; Newman AH
J Med Chem; 1994 Jul; 37(15):2285-91. PubMed ID: 8057277
[TBL] [Abstract][Full Text] [Related]
9. 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.
Ucar H; Cacciaguerra S; Spampinato S; Van derpoorten K; Isa M; Kanyonyo M; Poupaert JH
Eur J Pharmacol; 1997 Sep; 335(2-3):267-73. PubMed ID: 9369382
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide.
Vamecq J; Lambert D; Poupaert JH; Masereel B; Stables JP
J Med Chem; 1998 Aug; 41(18):3307-13. PubMed ID: 9719582
[TBL] [Abstract][Full Text] [Related]
11. Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents.
Calderon SN; Newman AH; Tortella FC
J Med Chem; 1991 Nov; 34(11):3159-64. PubMed ID: 1956032
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of docosahexaenoic acid on anticonvulsant activity of valproic acid and lamotrigine in animal seizure models.
Gavzan H; Sayyah M; Sardari S; Babapour V
Naunyn Schmiedebergs Arch Pharmacol; 2015 Oct; 388(10):1029-38. PubMed ID: 26018398
[TBL] [Abstract][Full Text] [Related]
15. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
Upton N; Blackburn TP; Campbell CA; Cooper D; Evans ML; Herdon HJ; King PD; Ray AM; Stean TO; Chan WN; Evans JM; Thompson M
Br J Pharmacol; 1997 Aug; 121(8):1679-86. PubMed ID: 9283703
[TBL] [Abstract][Full Text] [Related]
16. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
[TBL] [Abstract][Full Text] [Related]
17. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents.
Pontecorvo MJ; Karbon EW; Goode S; Clissold DB; Borosky SA; Patch RJ; Ferkany JW
Brain Res Bull; 1991 Mar; 26(3):461-5. PubMed ID: 1646668
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives.
Ucar H; Van derpoorten K; Cacciaguerra S; Spampinato S; Stables JP; Depovere P; Isa M; Masereel B; Delarge J; Poupaert JH
J Med Chem; 1998 Mar; 41(7):1138-45. PubMed ID: 9544213
[TBL] [Abstract][Full Text] [Related]
19. Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile.
Tortella FC; Robles L; Witkin JM; Newman AH
J Pharmacol Exp Ther; 1994 Feb; 268(2):727-33. PubMed ID: 8113984
[TBL] [Abstract][Full Text] [Related]
20. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes.
Nguyen VH; Kassiou M; Johnston GA; Christie MJ
Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
